Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
analgesic
opioid |
| gptkbp:antidote |
gptkb:naloxone
gptkb:naltrexone |
| gptkbp:associatedWith |
opioid epidemic
synthetic opioid crisis |
| gptkbp:ATCCode |
N01AH
|
| gptkbp:binds |
gptkb:mu-opioid_receptor
|
| gptkbp:CASNumber |
59708-52-0
|
| gptkbp:chemicalFormula |
C24H30N2O3
|
| gptkbp:compatibleWith |
human use
|
| gptkbp:detects |
toxicology screening
|
| gptkbp:discoveredBy |
gptkb:Paul_Janssen
|
| gptkbp:discoveredIn |
1974
|
| gptkbp:hasInChIKey |
YQKQYVJVQWQZEB-UHFFFAOYSA-N
|
| gptkbp:hasPotency |
about 10,000 times more potent than morphine
about 100 times more potent than fentanyl |
| gptkbp:hasSMILES |
CCC(=O)N(C1CCN(CC1)CC2=CC=CC=C2)C3=CC=CC=C3C(=O)OC
|
| gptkbp:hasUNII |
UQN4C7GNSN
|
| https://www.w3.org/2000/01/rdf-schema#label |
carfentanil
|
| gptkbp:isAbusedAs |
recreational drug
|
| gptkbp:isHighlyToxicTo |
animals
humans |
| gptkbp:isNotMarketedFor |
human use
|
| gptkbp:isUsedIllegallyAs |
cutting agent in street drugs
|
| gptkbp:IUPACName |
methyl 1-(2-phenylethyl)-4-(N-propanoylanilino)piperidine-4-carboxylate
|
| gptkbp:KEGGID |
D03441
|
| gptkbp:legalStatus |
Class A drug (UK)
Schedule II controlled substance (US) Schedule I controlled substance (Canada) |
| gptkbp:marketedAs |
Wildnil (veterinary use)
|
| gptkbp:molecularWeight |
394.51 g/mol
|
| gptkbp:parent |
fentanyl
|
| gptkbp:PubChem_CID |
gptkb:DB01535
56473 CHEMBL2104702 62737 |
| gptkbp:relatedTo |
gptkb:morphine
gptkb:remifentanil amphetamine opioid fentanyl alfentanil sufentanil |
| gptkbp:riskFactor |
high risk of accidental overdose
|
| gptkbp:routeOfAdministration |
injection
oral transdermal |
| gptkbp:sideEffect |
death
overdose respiratory depression |
| gptkbp:usedFor |
veterinary anesthesia
|
| gptkbp:usedOn |
large animals (e.g., elephants)
|
| gptkbp:bfsParent |
gptkb:FZ201
gptkb:WL-10 gptkb:diprenorphine |
| gptkbp:bfsLayer |
8
|